|
HYLS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.715800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.701600E-02 |
| Normal-vs-Stage2 |
6.972200E-01 |
| Normal-vs-Stage3 |
2.014500E-02 |
| Normal-vs-Stage4 |
4.061800E-02 |
| Stage1-vs-Stage2 |
9.685800E-02 |
| Stage1-vs-Stage3 |
2.688600E-01 |
| Stage1-vs-Stage4 |
3.926600E-01 |
| Stage2-vs-Stage3 |
3.303800E-02 |
| Stage2-vs-Stage4 |
5.027900E-02 |
| Stage3-vs-Stage4 |
9.880000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.792300E-02 |
| Normal-vs-AfricanAmerican |
1.857910E-03 |
| Normal-vs-Asian |
6.390200E-01 |
| Caucasian-vs-AfricanAmerican |
5.370200E-02 |
| Caucasian-vs-Asian |
5.053700E-02 |
| AfricanAmerican-vs-Asian |
3.724500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.006200E-01 |
| Normal-vs-Female |
4.837800E-02 |
| Male-vs-Female |
2.515400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.959900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.770500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.426600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.818200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.228200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.503800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.722400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.819800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.991000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.686800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.545800E-01 |
| Classical-VS-Follicular |
6.789400E-01 |
| Classical-VS-Other |
6.289600E-01 |
| Classical-VS-Normal |
1.174030E-01 |
| Tall-VS-Follicular |
2.610800E-01 |
| Tall-VS-Other |
9.937600E-01 |
| Tall-VS-Normal |
5.062400E-02 |
| Follicular-VS-Other |
5.370400E-01 |
| Follicular-VS-Normal |
2.540400E-01 |
| Other-VS-Normal |
4.427200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.568960E-01 |
| Normal-vs-N1 |
8.273800E-02 |
| N0-vs-N1 |
5.651000E-01 |
|
|
